NO971836L - Rekombinante Alternaria alternata allergener - Google Patents

Rekombinante Alternaria alternata allergener

Info

Publication number: NO971836L
Authority: NO; Norway
Prior art keywords: protein; allergens; alt; allergen; recombinant
Prior art date: 1994-11-02

Application number

NO971836A

Other languages

English (en)

Norwegian (no)

Other versions

NO971836D0 (no

Inventor

Gernot Achatz

Erich Lechenauer

Birgit Simon

Dietrich Kraft

Michael Breitenbach

Andrea Unger

Hannes Oberkofler

Christoph Ebner

Hans-Joerg Prillinger

Original Assignee

Biomay Prod & Handel

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-11-02

Filing date

1997-04-21

Publication date

1997-06-25

1997-04-21 Application filed by Biomay Prod & Handel filed Critical Biomay Prod & Handel

1997-04-21 Publication of NO971836D0 publication Critical patent/NO971836D0/no

1997-06-25 Publication of NO971836L publication Critical patent/NO971836L/no

Links

239000013566 allergen Substances 0.000 title abstract 6
241000223602 Alternaria alternata Species 0.000 title abstract 3
210000001744 T-lymphocyte Anatomy 0.000 abstract 3
206010020751 Hypersensitivity Diseases 0.000 abstract 2
102000002278 Ribosomal Proteins Human genes 0.000 abstract 2
108010000605 Ribosomal Proteins Proteins 0.000 abstract 2
208000026935 allergic disease Diseases 0.000 abstract 2
230000007815 allergy Effects 0.000 abstract 2
102000004196 processed proteins & peptides Human genes 0.000 abstract 2
108090000765 processed proteins & peptides Proteins 0.000 abstract 2
102000004169 proteins and genes Human genes 0.000 abstract 2
108090000623 proteins and genes Proteins 0.000 abstract 2
208000023275 Autoimmune disease Diseases 0.000 abstract 1
241000233866 Fungi Species 0.000 abstract 1
102000006010 Protein Disulfide-Isomerase Human genes 0.000 abstract 1
102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 1
108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 1
210000003719 b-lymphocyte Anatomy 0.000 abstract 1
230000000903 blocking effect Effects 0.000 abstract 1
239000002299 complementary DNA Substances 0.000 abstract 1
230000016396 cytokine production Effects 0.000 abstract 1
238000003745 diagnosis Methods 0.000 abstract 1
238000000338 in vitro Methods 0.000 abstract 1
238000001727 in vivo Methods 0.000 abstract 1
206010025135 lupus erythematosus Diseases 0.000 abstract 1
230000004492 positive regulation of T cell proliferation Effects 0.000 abstract 1
230000003389 potentiating effect Effects 0.000 abstract 1
108020003519 protein disulfide isomerase Proteins 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Mycology (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Enzymes And Modification Thereof (AREA)

NO971836A 1994-11-02 1997-04-21 Rekombinante Alternaria alternata allergener NO971836L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AT0203894A AT401181B (de)	1994-11-02	1994-11-02	Rekombinante dna moleküle
PCT/AT1995/000212 WO1996014407A1 (de)	1994-11-02	1995-10-31	Rekombinante alternaria alternata allergene

Publications (2)

Publication Number	Publication Date
NO971836D0 NO971836D0 (no)	1997-04-21
NO971836L true NO971836L (no)	1997-06-25

Family

ID=3526463

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO971836A NO971836L (no)	1994-11-02	1997-04-21	Rekombinante Alternaria alternata allergener

Country Status (8)

Country	Link
EP (1)	EP0787184A1 (de)
JP (1)	JPH10508474A (de)
AT (1)	AT401181B (de)
AU (1)	AU3736795A (de)
CA (1)	CA2204362A1 (de)
FI (1)	FI971894A7 (de)
NO (1)	NO971836L (de)
WO (1)	WO1996014407A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201209862D0 (en)	2012-06-01	2012-07-18	Circassia Ltd	Cladosporium peptides
CN116098124B (zh) *	2022-12-16	2025-02-11	中国医学科学院北京协和医院	利用Alt a 1对链格孢霉过敏性哮喘小鼠行皮下特异性免疫治疗模型的建立方法

1994
- 1994-11-02 AT AT0203894A patent/AT401181B/de active
1995
- 1995-10-31 WO PCT/AT1995/000212 patent/WO1996014407A1/de not_active Ceased
- 1995-10-31 JP JP8514890A patent/JPH10508474A/ja active Pending
- 1995-10-31 AU AU37367/95A patent/AU3736795A/en not_active Abandoned
- 1995-10-31 EP EP95935287A patent/EP0787184A1/de not_active Withdrawn
- 1995-10-31 FI FI971894A patent/FI971894A7/fi not_active Application Discontinuation
- 1995-10-31 CA CA002204362A patent/CA2204362A1/en not_active Abandoned
1997
- 1997-04-21 NO NO971836A patent/NO971836L/no unknown

Also Published As

Publication number	Publication date
ATA203894A (de)	1995-11-15
AT401181B (de)	1996-07-25
FI971894L (fi)	1997-05-02
JPH10508474A (ja)	1998-08-25
CA2204362A1 (en)	1996-05-17
AU3736795A (en)	1996-05-31
EP0787184A1 (de)	1997-08-06
WO1996014407A1 (de)	1996-05-17
NO971836D0 (no)	1997-04-21
FI971894A0 (fi)	1997-05-02
FI971894A7 (fi)	1997-05-02

Similar Documents

Publication	Publication Date	Title
Marre et al.	2018	Modifying enzymes are elicited by ER stress, generating epitopes that are selectively recognized by CD4+ T cells in patients with type 1 diabetes
Ooi et al.	2017	Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells
Born et al.	1990	Recognition of a peptide antigen by heat shock--reactive γδ T lymphocytes
CN103755789B (zh)	2016-12-07	调节性t细胞表位、组合物及其用途
Faigle et al.	2019	Brain citrullination patterns and T cell reactivity of cerebrospinal fluid-derived CD4+ T cells in multiple sclerosis
EP2170944B1 (de)	2014-04-09	Verfahren zur Diagnose von Type 1-Diabetes
EP0905518A1 (de)	1999-03-31	Peptiden spezifisch für Glutenempfindliche T-Zellen und Verwendung davon
Voigt et al.	2018	Unique glandular ex-vivo Th1 and Th17 receptor motifs in Sjögren's syndrome patients using single-cell analysis
Wucherpfennig	2001	Insights into autoimmunity gained from structural analysis of MHC–peptide complexes
DE69532605D1 (de)	2004-04-01	Peptidfragmente von mikrobiellen stressproteinen und daraus hergestellte pharmazeutische zusammensetzungen für die behandlung und vorbeugung von entzündungserkrankungen
KR20210041559A (ko)	2021-04-15	다발경화증에서의 면역우세 단백질 및 단편
Espinosa et al.	2013	Peptides presented by HLA class I molecules in the human thymus
Huang et al.	1997	Immunoglobulin superfamily proteins: structure, mechanisms, and drug discovery
Bakela et al.	2018	Soluble major histocompatibility complex molecules in immune regulation: highlighting class II antigens
WO2003072598A3 (en)	2003-12-24	Hsp70-derived peptides an uses thereof in the diagnosis and treatment of autoimmune diseases
Maggi et al.	2022	Isolation of HLA-DR-naturally presented peptides identifies T-cell epitopes for rheumatoid arthritis
Koşaloğlu‐Yalçın et al.	2021	Comparison of HLA ligand elution data and binding predictions reveals varying prediction performance for the multiple motifs recognized by HLA‐DQ2. 5
Baxevanis et al.	1989	Peptides of myelin basic protein stimulate T lymphocytes from patients with multiple sclerosis
NO971836L (no)	1997-06-25	Rekombinante Alternaria alternata allergener
RU2005106841A (ru)	2005-10-27	Эпитопы т-клеток в эритропоэтине
DK1546188T3 (da)	2008-10-27	P53-bindende T-cellereceptormolekyler og anvendelser deraf
Potter et al.	1992	Acute optic neuritis associated with immunization with the CNS myelin proteolipid protein.
NO960553L (no)	1996-04-12	T-celle-epitoper av raigresspollen-allergen
Liukko et al.	2014	Human CD4+ T cell responses to the dog major allergen Can f 1 and its human homologue tear lipocalin resemble each other
Kasai et al.	1993	Proenzyme form of cathepsin L produced by thymic epithelial cells promotes proliferation of immature thymocytes in the presence of IL-1, IL-7, and anti-CD3 antibody